GATA3 and myeloid sarcoma: The current study revealed that the T-bet/GATA-3 expression ratio in non-stimulated, MOG-stimulated, and PHA-stimulated PBMCs of patients with MS were higher than those of the same cell cultures from the healthy individuals.